Efficacy of Sensory Reweighting Techniques for Balance and Risk of Fall in Chronic Ischemic Stroke Patients
SRT-IS
1 other identifier
interventional
46
1 country
1
Brief Summary
This randomized controlled trial will evaluate the effectiveness of sensory reweighting techniques on balance and risk of falls in individuals with chronic ischemic stroke. A total of 46 participants will be recruited using purposive sampling and randomly assigned into two groups through the sealed envelope method. Balance and fall risk will be assessed using the Berg Balance Scale and the Timed Up and Go test at baseline and after completion of the intervention. Participants in the experimental group will receive sensory reweighting-based balance training three times per week for eight weeks, incorporating altered sensory conditions such as reduced visual input, unstable surfaces, and vestibular challenges. The control group will receive conventional balance training of similar duration and intensity without sensory manipulation. Both groups will also receive standard physiotherapy throughout the intervention period. Ethical approval will be obtained prior to data collection, written informed consent will be secured from all participants, and confidentiality and voluntary participation will be ensured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedStudy Start
First participant enrolled
February 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2026
CompletedFebruary 17, 2026
February 1, 2026
2 months
February 4, 2026
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Balance Performance
Balance will be measured using the Berg Balance Scale (BBS), a validated clinical tool consisting of 14 functional tasks assessing postural control, stability, and fall risk in chronic ischemic stroke patients. Each task is scored from 0 (unable to perform) to 4 (independent and safe), with a maximum total score of 56. Higher scores indicate better balance, and scores below 45 suggest increased risk of falls. Assessments will be conducted at baseline and after completion of the 8-week intervention to evaluate the efficacy of sensory reweighting balance training compared to conventional balance exercises.
Baseline and 8 weeks post-intervention
Secondary Outcomes (1)
Risk of Falls
Baseline and 8 weeks post-intervention
Study Arms (2)
group A Sensory Reweighting Balance Training Group
EXPERIMENTALParticipants in this arm will receive sensory reweighting-based balance training aimed at enhancing integration of visual, vestibular, and somatosensory inputs for postural control. The intervention will be delivered three times per week for eight weeks, with each session lasting approximately 45 minutes. Training will include balance tasks performed under altered sensory conditions such as reduced visual input, compliant surfaces, head movements, and dual-task activities. Exercise difficulty will be progressively increased according to individual tolerance while ensuring participant safety.
group B Conventional Balance Training Group
ACTIVE COMPARATORParticipants in this arm will receive conventional balance training without sensory reweighting components. The program will be delivered three times per week for eight weeks, with each session lasting approximately 45 minutes. Exercises will focus on static and dynamic balance tasks, including standing with a narrow base, sit-to-stand practice, and forward/backward walking. No manipulation of sensory input will be included. Training intensity and duration will be matched to the experimental group to allow fair comparison of outcomes.
Interventions
Participants will receive sensory reweighting-based balance training aimed at improving postural control by enhancing the central nervous system's ability to integrate visual, vestibular, and somatosensory inputs. Training will be conducted three times per week for eight weeks, with 45-minute sessions including warm-up, core balance exercises, and cool-down. Exercises will be performed under altered sensory conditions, such as standing on foam surfaces, performing tasks with eyes closed, head movements during stance and gait, and dual-task activities. Task difficulty will be progressively increased based on individual tolerance while maintaining safety.
Participants will receive conventional balance training without sensory reweighting components. The program will be delivered three times per week for eight weeks, with each session lasting approximately 45 minutes. Exercises will focus on static and dynamic balance tasks such as standing with a narrow base, sit-to-stand practice, and forward/backward walking. No manipulation of sensory input will be included. Training intensity and duration will be matched to the experimental group to ensure comparability of outcomes.
Eligibility Criteria
You may qualify if:
- Diagnosed case of chronic ischemic stroke (duration \>6 months post-stroke)
- Both male and female patients with age range 40-60 years .
- Able to stand and walk at least 10 feet (with or without assistive devices).
- Mini-Mental State Examination (MMSE) score ≥24 (to ensure adequate cognitive ability to follow instructions).
- Medically stable and cleared by a physician to participate in balance training.
- Experiencing balance impairment and/or history of at least one fall in the past 6 months
You may not qualify if:
- Hemorrhagic stroke patients or mixed stroke types
- Severe visual, auditory, or vestibular impairments not correctable by aids (which would interfere with sensory reweighting assessment).
- Other neurological conditions (e.g., Parkinson's disease, multiple sclerosis, peripheral neuropathy).
- Musculoskeletal disorders significantly affecting balance (e.g., recent fracture, severe arthritis).
- On medications that severely affect balance or cause dizziness (e.g., sedatives, high-dose antiepileptic.
- Severe aphasia or communication disorders impeding participation in the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montiha Azeemlead
Study Sites (1)
University of Lahore Teaching Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
Study Officials
- PRINCIPAL INVESTIGATOR
Kanwal Mirani, MSPTN
The University of Lahore, Lahore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 11, 2026
Study Start
February 15, 2026
Primary Completion
April 15, 2026
Study Completion
April 18, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02